Trial Outcomes & Findings for Experimental Tinnitus Treatment With Transcranial Magnetic Stimulation (NCT NCT03699826)

Last Updated: 2023-07-11

Results Overview

Clinical Global Improvement Scale (0-7 scale where 0=not assessed, 1=Very much improved, and 7= Very much worse

Recruitment status

TERMINATED

Study phase

Target enrollment

1 participants

Primary outcome timeframe

End of treatment course - 5 days

Results posted on

2023-07-11

Participant milestones
Measure	TMS for Tinnitus TMS for tinnitus: Open label study of neuro-navigated transcranial magnetic stimulation evaluating different stimulation sites and different stimulation protocols to decrease tinnitus symptom severity. Our goal was to evaluate whether a trial-and-error targeting session could be useful in selecting the stimulation site and frequency of stimulation before conducting daily treatments.
Overall Study STARTED	1
Overall Study COMPLETED	1
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Experimental Tinnitus Treatment With Transcranial Magnetic Stimulation

Baseline characteristics by cohort
Measure	TMS for Tinnitus n=1 Participants TMS for tinnitus: Open label study of neuro-navigated transcranial magnetic stimulation evaluating different stimulation sites and different stimulation protocols to decrease tinnitus symptom severity. Our goal was to evaluate whether a trial-and-error targeting session could be useful in selecting the stimulation site and frequency of stimulation before conducting daily treatments.
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	1 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants
Age, Continuous	65 years n=5 Participants
Sex: Female, Male Female	0 Participants n=5 Participants
Sex: Female, Male Male	1 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=5 Participants
Race (NIH/OMB) Asian	0 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	0 Participants n=5 Participants
Race (NIH/OMB) White	1 Participants n=5 Participants
Race (NIH/OMB) More than one race	0 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants

Timeframe: End of treatment course - 5 days

Population: single patient

Clinical Global Improvement Scale (0-7 scale where 0=not assessed, 1=Very much improved, and 7= Very much worse

Outcome measures
Measure	TMS Treatment (Open Label, N = 1) n=1 Participants TMS for tinnitus: Targeted stimulation to decrease tinnitus symptom severity.
Clinical Improvement	4 score on a scale

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

University of Iowa

Phone: 319-353-8587